Stimulation of sodium transport by aldosterone in the isolated toad bladder has been clearly demonstrated. '-3 In this preparation sodium transport can be readily measured as the equivalent short-circuit current.4' 5 The corticosteroids have been found to affect the short-circuit current in accord with their known effects on renal sodium excretion in man. Aldosterone, the most potent sodium-retaining hormone in man, will induce a graded augmentation of sodium transport in the toad bladder over a concentration range of 3 X 10-10 to 1 X 10-7 M in the bathing medium.3 Recent studies on the competitive binding of aldosterone and other corticosteroids have been reported,6 as have the studies by Edelman, Bogoroch, and Porter7' 8 which suggest that the action of aldosterone is mediated through a DNA-dependent synthesis of RNA.
Stimulation of sodium transport by aldosterone in the isolated toad bladder has been clearly demonstrated. '-3 In this preparation sodium transport can be readily measured as the equivalent short-circuit current.4' 5 The corticosteroids have been found to affect the short-circuit current in accord with their known effects on renal sodium excretion in man. Aldosterone, the most potent sodium-retaining hormone in man, will induce a graded augmentation of sodium transport in the toad bladder over a concentration range of 3 X 10-10 to 1 X 10-7 M in the bathing medium.3 Recent studies on the competitive binding of aldosterone and other corticosteroids have been reported,6 as have the studies by Edelman, Bogoroch, and Porter7' 8 which suggest that the action of aldosterone is mediated through a DNA-dependent synthesis of RNA.
The purpose of the present communication is to demonstrate that the action of aldosterone is specifically and markedly to sensitize the sodium transport system in this tissue to pyruvate. In the presence of aldosterone, but not in its absence, small concentrations (-10-3 M) of pyruvate will induce prompt and sustained stimulation of sodium transport. Only pyruvate and, to a lesser extent, those substrates known to yield pyruvate during the course of their metabolism-i.e., glucose, lactate, and oxalacetate-have been found to -possess this stirnulatory effect in the aldosterone-treated bladder.
Methods.-Measurements of sodium transport have been made in the double chamber in which the activity of two portions of tissue from the same half bladder may be separately monitored, allowing one to serve as the control for the other. 3 The tissue has been found to be most responsive to the effects of substrates if it is mounted in the chamber and exposed to aldosterone over the 6-12 hr preceding addition of substrates. By this time the characteristic initial stimulation of sodium transport by aldosterone3 has largely subsided, and the differences between rates of transport in the control and aldosterone-treated tissue are small. Bladders were promptly removed from toads which had been maintained 12-72 hr in isotonic saline in order to minimize the effect on the tissues of endogenous aldosterone. Using the North American bullfrog, Ulick9 has demonstrated suppression of endogenous secretion of aldosterone in animals kept in saline solutions.
The majority of experiments were performed in a frog-Ringer's solution containing: Na+, 115; K+, 3.5; Cl-, 116.5; HCO3-, 2.4; mEq/l and Ca, 0.89 and P04, 2 mM. The pH in air of this solution was 7.6 and the total solute concentration 232 mOsm. Similar effects were obtained without the 2mM phosphate or with all bicarbonate deleted from the Ringer's solution and the phosphate serving as buffer.
d-Aldosterone was added in 5 ;sl of methanol to the medium bathing the serosal side of the tissue at final concentrations of 1.25 X 10-7 M. The vehicle was added to the control. Substrates were added to yield final concentrations of 5 mM in the bathing medium except in the case of pyruvate, the concentrations of which varied from 0.1 to 5 mM, as indicated. All substrates were added as their neutral sodium salts. The oxygen consumption was measured under various conditions of substrate utilization by conventional manometric techniques10 at 20°C using the bicarbonate-free Ringer's solution as the incubation medium. Paired tissues, 30-60 mg dry weight, were preincubated in Warburg vessels containing 3 ml of medium with 0.3 mg of penicillin, 0.3 mg of streptomycin, 1.25 X 10-7 M d-aldosterone or, in the controls, 5 ,uA of methanol. After 6-10 hr the tissues were transferred to fresh medium and flasks containing, in addition, 5 mM sodium acetate. Measurements of 02 cOnD sumption were made for two consecutive hr; then pyruvate was tipped into the medium from the side arm to give a final concentration of 1.33 mM. Oxygen consumption was measured for another hour.
C1402 release was measured by passing all the air used to aerate and stir the medium in the double chambers through trains of 2 tubes each containing 1.0 ml of 0.5 M hydroxide of Hyamine" in methanol. In the first tube 99-100% of the radioactivity was trapped. After 60 min of exposure of the tissue to the labeled substrate, the reaction was terminated by the injection of 0.25 ml of 2 N H2SO4 into the 4 ml of medium bathing each surface of the tissue, and aeration was continued for a further period of 20 or 30 min to transfer all CO2 to the alkaline trap. The Hyamine-methanol solution with the trapped radioactivity was quantitatively transferred to a toluene scintillation mixture and the radioactivity measured in a TriCarb liquid scintillation spectrometer.'2 The chamber was carefully opened, the tissue excised, blotted, and its dry weight obtained.
Adenosine triphosphate concentrations in the tissue were assayed by the luciferase method.'3 Concentrations of adenosine triphosphate were measured in tissues incubated in the double chamber or in Warburg flasks.
From the New England Nuclear Corp., Boston, 1-C'4, 2-C4, and 3-C14 pyruvate and 1-C'4 acetate were obtained. Volatility of the labeled substrate was determined under conditions of the experiment and the appropriate blank subtracted from the radioactivity trapped in the Hyamine.
With 1-C'4 pyruvate this blank amounted to 4.9% of the counts in the Hyamine. 0.1 mg of penicillin G and 0.1 mg of streptomycin sulfate were added per ml of medium to inhibit bacterial utilization of substrate in all experiments in which oxygen consumption or substrate utilization was determined. 14 15 Results.-Substrate effects on sodium transport: Figure 1 shows that addition of 1 mM pyruvate to both control and aldosterone-treated portions of tissue resulted in stimulation of sodium transport only in the latter. Subsequent exposure of the control tis3ue to 1.25 X 10-M d-aldosterone doubled the rate of sodium transport, bringing it up to that of the tissue previously treated with aldosterone. In 50 experiments we have seen absolutely no effect of the pyruvate in the absence of aldosterone, while in 12 experiments a small effect was observed in the control. In the latter instances we suspect some small residual endogenous aldosterone activity. The pyruvate response is elicited by concentrations of 0.1-1 mM in the medium bathing the serosal surface of the tissue. Concentrations of 5 mM induced little or no effect above that seen with 1 mM pyruvate, and addition of pyruvate to the medium bathing the mucosal surface was totally ineffective at -A~dosterone 610cose1 NO acteristically produced a small depression of transport as seen in Figure 4 which contrasts the effects of 5 mM acetate with those of 1.0 m\I pyruvate. Since puromycin and actinomycin D specifically abolish the primary stimulation of sodium transport by aldosterone in our preparation, it was of interest to see whether the secondary stimulation by pyruvate in the presence of aldosterone would likewise be inhibited by these agents. Figure 5 shows that 8 X 10-5 M puromycin added together with the pyruvate to one portion of the tissue effectively blocked its subsequent response to pyruvate.
Metabolic effects of substrates: Table 1A shows the effects of aldosterone and of pyruvate on oxygen consumption by the toad bladder. The values shown are the Q02 (Al 02 consumed per mg dry weight of tissue per hr) for the one hour prior to and the one hour following addition of pyruvate in 12 paired experiments. The addition of pyruvate was associated with a small but significant decline in oxygen consumption in both the aldosterone-treated and control tissues. However, both before and following addition of pyruvate, the aldosterone-treated tissue was conuming more oxygen than its paired control (0.87 to 0.75 and 0.82 to 0.67), and these differences proved to be statistically significant (p < 0.01 in both instances). (Table iD F-4 qpWOO 0 and E, respectively), the oxidation of acetate was greater in the aldosterone-treated tissue ¢ | a,_ 0,> *0 than in the control, and the differences are°| w°°°. E;~l4 statistically significant. of the essential role of thiamine in the decarboxylation of pyruvate, has been tested. The addition of 0.5 mM oxythiamine together with aldosterone has been found to depress or abolish the expected stimulation of sodium transport subsequent to the addition of pyruvate, as shown in Figure 6 . Under these conditions the decarboxylation of 1-C'4 pyruvate has been found to be depressed approximately to one third the rate observed in the paired portion of tissue unexposed to oxythiamine. In these experiments acetate, citrate, and succinate (each 0.5 mM) were present in the bathing medium to minimize interference by the oxythiamine with the tricarboxylic acid cycle.
Discussion.-Thus far we have found only pyruvate and substances which readily yield pyruvate in the course of their metabolism, i.e., glucose, lactate, and oxalacetate, to produce stimulation of sodium transport in the aldosterone-treated bladder. A period of preincubation in the absence of available exogenous substrate seems necessary to enhance the sensitivity of the tissue to pyruvate. When pyruvate is added at the peak of the initial aldosterone effect, no augmentation of sodium transport results, but the effect of aldosterone is distinctly prolonged.
As puromycin specifically prevents both the initial effect of aldosterone and the later response to pyruvate, it is suggested that the two effects are identical. Presumably the fresh tissue responding to aldosterone alone has an adequate supply of precursor available in the form of glycogen.'7 Only when endogenous sources are depleted does response to exogenous supply become marked.
The results indicate that aldosterone has an action on the tissue (presumably to induce synthesis of some protein according to the findings of Edelman and associates7' 8) which creates a sensitivity of the transport system to pyruvate where none exists in the absence of aldosterone. In defining the role of pyruvate the important question is whether pyruvate serves as a unique energy-supplying substrate for sodium transport when aldosterone is present. Since acetate and members of the tricarboxylic acid cycle (with the exception of oxalacetate) are entirely without this effect and yet acetate, at least, has been shown here to be utilized by this tissue, any metabolic effect of pyruvate subsequent to its decarboxylation and formation of acetyl coenzyme A may be excluded. This would leave the oxidative decarboxylation of pyruvate with reduction of DPN as the unique reaction providing energy for sodium transport. The control tissue in the absence of aldosterone is itself actively engaged in utilizing pyruvate (Table 1) , and thus aldosterone would have to create the conditions for decarboxylation of pyruvate at some separate site in the tissue where the energy which resulted could be entirely coupled to sodium transport. As there are two major cell types in this epithelium which appear to be likely candidates for transporting sodium,'8' '9 the suggestion is made that the mitochondrial-rich cells are activated to transport sodium by aldosterone, whereas the predominant epithelial cell maintains the basal level of transport which proceeds in the absence of aldosterone or even when the effect of aldosterone is blocked by puromycin or actinomycin D.
Edelman and associates7 have suggested that aldosterone induces the formation of enzymes involved in the oxidation of pyruvate. The present study would limit this possibility specifically to pyruvic decarboxylase. This hypothesis would appear to be supported by the higher rate of pyruvate utilization by the aldosteronetreated tissue than by the control tissue (Table 1C ) and the effect of oxythiamine in inhibiting both the sodium transport stimulated by pyruvate and the decarboxylation of the latter. Certain evidence from the present study, however, suggests a more complex action of the hormone. This evidence may be summarized as follows: (1) the absence of any detectable stimulation of oxygen consumption by addition of pyruvate to the aldosterone-treated tissue; (2) the finding that the rate of oxygen consumption by the tissue treated with aldosterone is greater than the control even prior to addition of pyruvate; (3) the finding that acetate, which itself does not stimulate sodium transport, is also utilized more rapidly by the aldosteronetreated tissue than by the control tissue whether or not pyruvate is present; (4) comparison of the increment in sodium transport and in the simultaneously determined increment of C02 released from 1-C'4 pyruvate in the aldosterone-treated tissue yields an inordinately high figure of 40 sodium ions transported per molecule of extra pyruvate decarboxylated or 13 + 1.6 (S.E.) sodium ions transported per high energy phosphate bond formed.20 These figures were calculated from 10 of the 12 measurements recorded in Table 1 because a very high ratio of 118 (Na/P) was obtained in one experiment and a negative value in another.
As some 10-20 per cent of the resting metabolism of transporting epithelia like the toad bladder has been estimated as the minimal portion required for sodium transport,17 21 the absence of any detectable stimulation of oxygen consumption upon addition of pyruvate suggests a diversion of some of the basal oxygen consumption for transport work in the presence of aldosterone.
It is of interest that the ratios of oxygen consumption, of acetate utilization, and of 1-C'4 pyruvate decarboxylation by the aldosterone-treated to control tissues are all of approximately the same magnitude-1.18 and 1.24 for oxygen consumption, and 1.48 and 1.24 for acetate utilization with and without pyruvate, respectively, and 1.43 for pyruvate alone. Furthermore, the rate of sodium transport by the aldosterone-treated tissue compared with that of the control yields a ratio of 1.42. (See Table lE for the values of sodium transport measured simultaneously with acetate utilization in the absence of pyruvate.) The similarity of the ratios in all instances suggests a slightly higher rate of metabolism in the aldosterone-treated tissue associated with its slightly higher rate of sodium transport.
Finally, the ratios of extra sodium transported to extra pyruvate utilized give a much higher mean value, 13, for the number of sodium ions transported per high energy phosphate bond synthesized than the previously estimated figure of 3 for this tissue' and the related sodium transport system in frog skin.21 22 Recently, however, the high value of 8 has been reported for this ratio by Chance and associates23 in studies with the salt glands of the herring gull. The significance of these quantitative relationships is weakened by the possibility of an alteration in the metabolism of pyruvate induced by aldosterone so that in the presence of the hormone more of the pyruvate consumed is used for sodium transport. A diversion of the basal oxygen consumption to support transport in the presence of aldosterone has been indicated above. Thus, the results are compatible with an action of aldosterone to couple the energy yielded by the decarboxylation of pyruvate to the transport of sodium.
Summary.-The stimulation of sodium transport by aldosterone in the isolated urinary bladder of the toad Bufo marinus is specifically and markedly enhanced by pyruvate. In the presence of aldosterone, but not in its absence, small concentra-
